Wanbangde Pharmaceutical Holding Group News

Wan Bond: Announcement on the establishment of a wholly-owned subsidiary

Dec 13 11:00 ET

Wan Bond: Notice on Wholly-owned Subsidiary Drugs Obtaining Conformity Evaluation Registration Approval

Nov 17 11:00 ET

Wan Bond: Announcement on the Resignation of Director and Chief Financial Officer

Sep 29 12:00 ET

Wan Bond: Summary table of non-operating capital usage and other related capital transactions for the first half year

Aug 28 12:00 ET

Wan Bond: 2024 semi-annual financial report

Aug 28 12:00 ET

Wanbangde Pharmaceutical Holding Group: Announcement on the signing of the "Compensation Agreement for the Acquisition of Houses on State-owned Land" by the subsidiary.

Aug 12 12:00 ET

Wanbangde Pharmaceutical Holding Group: Announcement on the subsidiary's products being certified as orphan drugs by the US FDA

May 29 12:00 ET

Wanbangde Pharmaceutical Holding Group: Wan Bond's 2023 Annual General Meeting of Shareholders Legal Opinion

May 17 12:00 ET

Wanbangde Pharmaceutical Holding Group: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders

May 17 12:00 ET

Wanbangde Pharmaceutical Holding Group: Notice on convening the 2023 Annual General Meeting of Shareholders (after correction)

May 15 12:00 ET

Wanbangde Pharmaceutical Holding Group: Corrective Notice Concerning the Notice of Convening the 2023 Annual General Meeting of Shareholders

May 15 12:00 ET

Wanbangde Pharmaceutical Holding Group: Notice on subsidiary products receiving US FDA drug certification for rare pediatric diseases

May 7 12:00 ET

Wanbangde Pharmaceutical Holding Group: Notice of Annual General Meeting of Shareholders

Apr 25 12:00 ET

Wanbangde Pharmaceutical Holding Group: Remuneration and Committee Rules of Procedure (2024.4)

Apr 25 12:00 ET

Wanbangde Pharmaceutical Holding Group: Internal Control Self-Assessment Report

Apr 25 12:00 ET

Wanbangde Pharmaceutical Holding Group: Announcement on preparing to accrue asset impairment

Apr 25 12:00 ET

Wanbangde Pharmaceutical Holding Group: Shareholder return plan for the next three years (2024-2026)

Apr 25 12:00 ET

Wanbangde Pharmaceutical Holding Group: 2023 Financial Results Report

Apr 25 12:00 ET

Wan Bond: Announcement on the wholly-owned subsidiary passing the Korean MFDS on-site inspection

Apr 10 12:00 ET

Wan Bond: Announcement on cooperative investment between wholly-owned subsidiaries and professional investment institutions

Mar 5 11:00 ET